Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

clinical benefit

- PMLiVE

The trouble with insights

Using health psychology to address medicines adherence is a rapidly developing area, but one that is poorly understood by many companies operating in the space

- PMLiVE

Guiding decisions

How the ever-changing face of market research continues to impact the healthcare industry

- PMLiVE

Social media and inflation penalties for generic drugs

US generic drug companies are under more scrutiny as the US public becomes more vocal 

- PMLiVE

How AbbVie Care is putting patients at the centre

And why this is good news for everyone

- PMLiVE

Pharma’s reputation rises, but pricing still a sore point

Patient group survey sees the industry's corporate reputation increase

- PMLiVE

A better direction

Could behavioural science be the key to improving patient outcomes?

- PMLiVE

The new EU clinical trial lay summaries

New regulations will require both a trial summary and a lay person’s summary

The new EU clinical trial lay summaries

New regulations will require both a trial summary and a lay person’s summary

- PMLiVE

Changing behaviour by design

Are we underestimating the power of design in encouraging behaviours for the good of our health?

- PMLiVE

US precision medicine push gathers momentum

Hopes to ‘revolutionise’ medicines through creation of shared healthcare databases

- PMLiVE

The price is right?

To market new innovation against a backdrop of restricted budgets, companies must work hard - and start early

- PMLiVE

A five-step plan for patient-centred digital communications

Every functional area should be able to interact with patients

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links